EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 122 participants.
Also called NCT06386874
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose supportive care
- Phase
- Not applicable
- Enrolled
- 122 participants
- Sponsor
- BrainQ Technologies Ltd.
- Registry
-
NCT06386874
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06386874. Randomized; quadruple masking; primary purpose supportive care. Start 2024-08-20 (actual); primary completion 2026-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment
- Condition
- Ischemic Stroke
- Intervention (Device)
- Q Therapeutic System (BQ 3.0) - Sham
- Intervention (Device)
- Q Therapeutic System (BQ 3.0) - Active
- Lead sponsor
- BrainQ Technologies Ltd.
Record details
- Record id
cardio:ct-nct06386874- Content hash
9eb25088016aca738a0bf26ae1d88d468f934689ae2ca617178065b1fcb9d111